Locus Cell Co Ltd

NEW
ROCO:6891 (Taiwan)  
NT$ 39.8 -0.20 (-0.5%) Aug 12
At Loss
P/B:
5.13
Market Cap:
NT$ 7.98B ($ 248.43M)
Enterprise V:
NT$ 7.52B ($ 234.09M)
Volume:
99.95K
Avg Vol (2M):
419.68K
Trade In:
Volume:
99.95K
At Loss
Avg Vol (2M):
419.68K

Business Description

Description
Locus Cell Co Ltd is mainly engaged in the contract development and manufacturing of cellular therapy products as a Contract Development and Manufacturing Organization (CDMO). The Group operates in a single industry, providing contract development and manufacturing of cell therapy-related products with similar end-use applications. It operates in Taiwan, Japan, and the United States, with the majority of its revenue generated from Japan.
Name Current Vs Industry Vs History
Cash-To-Debt
2.54
Equity-to-Asset
0.82
Debt-to-Equity
0.19
Debt-to-EBITDA
-2.03
Piotroski F-Score
2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
13.7
Distress
Grey
Safe
Beneish M-Score
0.97
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Revenue Growth Rate
177.3
3-Year EBITDA Growth Rate
-53.4
3-Year EPS without NRI Growth Rate
-49.9
3-Year FCF Growth Rate
-113
3-Year Book Growth Rate
-6.8

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
49.24
9-Day RSI
46.04
14-Day RSI
43.65
3-1 Month Momentum %
-24.15
6-1 Month Momentum %
66.67
12-1 Month Momentum %
87.63

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
13.58
Quick Ratio
13.52
Cash Ratio
12.34
Days Inventory
189.29
Days Sales Outstanding
17.65
Days Payable
32.62

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield %
-1.47

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin %
49.25
Operating Margin %
-1370.51
Net Margin %
-1425.2
EBITDA Margin %
-1156.18
FCF Margin %
-4717.09
OCF Margin %
-1325.35
ROE %
-11.12
ROA %
-10.02
ROIC %
-20.05
3-Year ROIIC %
-8.47
ROC (Joel Greenblatt) %
-21.2
ROCE %
-10.16

Financials

ROCO:6891's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Locus Cell Co Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil NT$) 12.738
EPS (TTM) (NT$) -0.911
Beta -
3-Year Sharpe Ratio 0.3
3-Year Sortino Ratio 1.31
Volatility % 238.41
14-Day RSI 43.65
14-Day ATR (NT$) 2.283882
20-Day SMA (NT$) 39.8425
12-1 Month Momentum % 87.63
52-Week Range (NT$) 23.3 - 94.7
Shares Outstanding (Mil) 200.57

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Locus Cell Co Ltd Filings

Filing Date Document Date Form
No Filing Data

Locus Cell Co Ltd Stock Events

Financials Calendars
Event Date Price (NT$)
No Event Data

Locus Cell Co Ltd Frequently Asked Questions

What is Locus Cell Co Ltd(ROCO:6891)'s stock price today?
The current price of ROCO:6891 is NT$39.80. The 52 week high of ROCO:6891 is NT$94.70 and 52 week low is NT$23.30.
When is next earnings date of Locus Cell Co Ltd(ROCO:6891)?
The next earnings date of Locus Cell Co Ltd(ROCO:6891) is .
Does Locus Cell Co Ltd(ROCO:6891) pay dividends? If so, how much?
Locus Cell Co Ltd(ROCO:6891) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on Locus Cell Co Ltd

No articles.